FAME study can continue without change
pSivida Limited has announced that the FAME™ (Fluocinolone Acetonide in Diabetic Macular Edema) Study can continue under the current protocol. The trial is studying the use of Medidur FA in diabetic macular edema (DME). The FAME™ study is being conducted on 956 patients in the U.S., Canada, Europe and India and it consists of two, duplicate, double-masked, randomized and multi-center trials.
- Study: New age disposable lens prevents corneal infection
- Diabetic women more prone to glaucoma
- Doctors find a more effective treatment for convergence insufficiency
- GPR91 receptor can be key to eye health
